Registro:

Referencias:

• Maris, J.M., Hogarty, M.D., Bagatell, R., Cohn, S.L., Neuroblastoma (2007) Lancet, 369 (9579), pp. 2106-2120. , DOI 10.1016/S0140-6736(07)60983-0, PII S0140673607609830
• Cohn, S.L., Pearson, A.D., London, W.B., Monclair, T., Ambros, P.F., Brodeur, G.M., Faldum, A., Simon, T., The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report (2009) J Clin Oncol, 27, pp. 289-297
• Berthold, F., Boos, J., Burdach, S., Erttmann, R., Henze, G., Hermann, J., Klingebiel, T., Hero, B., Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: A randomised controlled trial (2005) Lancet Oncology, 6 (9), pp. 649-658. , DOI 10.1016/S1470-2045(05)70291-6, PII S1470204505702916
• Pearson, A.D., Pinkerton, C.R., Lewis, I.J., Imeson, J., Ellershaw, C., Machin, D., High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: A randomised trial (2008) The Lancet Oncology, 9 (3), pp. 247-256. , DOI 10.1016/S1470-2045(08)70069-X, PII S147020450870069X
• Gray, J.C., Kohler, J.A., Immunotherapy for neuroblastoma: Turning promise into reality (2009) Pediatr Blood Cancer, 53, pp. 931-940
• Yu, A.L., Gilman, A.L., Ozkaynak, M.F., London, W.B., Kreissman, S.G., Chen, H.X., Smith, M., Grupp, S.A., Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma (2010) N Engl J Med, 363, pp. 1324-1334
• Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Immunosuppressive strategies that are mediated by tumor cells (2007) Annual Review of Immunology, 25, pp. 267-296. , DOI 10.1146/annurev.immunol.25.022106.141609
• Camby, I., Le, M.M., Lefranc, F., Kiss, R., Galectin-1: A small protein with major functions (2006) Glycobiology, 16 (11), pp. 137R-157R. , DOI 10.1093/glycob/cwl025
• Le Mercier, M., Fortin, S., Mathieu, V., Roland, I., Spiegl-Kreinecker, S., Haibe-Kains, B., Bontempi, G., Kiss, R., Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression (2009) Neoplasia, 11, pp. 485-496
• Liu, F.-T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nature Reviews Cancer, 5 (1), pp. 29-41. , DOI 10.1038/nrc1527
• Liu, F.T., Rabinovich, G.A., Galectins: Regulators of acute and chronic inflammation (2010) Ann N Y Acad Sci, 1183, pp. 158-182
• Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5 (3), pp. 241-251. , DOI 10.1016/S1535-6108(04)00024-8, PII S1535610804000248
• Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc Natl Acad Sci USA, 7 (104), pp. 13134-13139
• Kuo, P.L., Hung, J.Y., Huang, S.K., Chou, S.H., Cheng, D.E., Jong, Y.J., Hung, C.H., Huang, M.S., Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway (2011) J Immunol, 186, pp. 1521-1530
• Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Giaccia, A.J., Le, Q.T., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431
• Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., Chen, M., Jiang, K., High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2011) Int J Cancer, , DOI: 10.1002/ijc.26290
• Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Rabinovich, G.A., Differential glycosylation of TH1, TH2 and T H-17 effector cells selectively regulates susceptibility to cell death (2007) Nature Immunology, 8 (8), pp. 825-834. , DOI 10.1038/ni1482, PII NI1482
• Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat Immunol, 10, pp. 981-991
• Camby, I., Belot, N., Lefranc, F., Sadeghi, N., De Launoit, Y., Kaltner, H., Musette, S., Kiss, R., Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases (2002) Journal of Neuropathology and Experimental Neurology, 61 (7), pp. 585-596
• Le Mercier, M., Fortin, S., Mathieu, V., Kiss, R., Lefranc, F., Galectins and gliomas (2010) Brain Pathol, 20, pp. 17-27
• Cimmino, F., Schulte, J.H., Zollo, M., Koster, J., Versteeg, R., Iolascon, A., Eggert, A., Schramm, A., Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness (2009) Oncogene, 28, pp. 2015-2023
• Rabinovich, G.A., Daly, G., Dreja, H., Tailor, H., Riera, C.M., Hirabayashi, J., Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J Exp Med, 190, pp. 385-398
• Lutz, M.B., Kukutsch, N., Ogilvie, A.L.J., Rossner, S., Koch, F., Romani, N., Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow (1999) Journal of Immunological Methods, 223 (1), pp. 77-92. , DOI 10.1016/S0022-1759(98)00204-X, PII S002217599800204X
• Fest, S., Huebener, N., Weixler, S., Bleeke, M., Zeng, Y., Strandsby, A., Volkmer-Engert, R., Lode, H.N., Characterization of GD2 peptide mimotope DNA vaccines effective against spontaneous neuroblastoma metastases (2006) Cancer Research, 66 (21), pp. 10567-10575. , DOI 10.1158/0008-5472.CAN-06-1158
• Fest, S., Huebener, N., Bleeke, M., Durmus, T., Stermann, A., Woehler, A., Baykan, B., Hohn, O., Survivin minigene DNA vaccination is effective against neuroblastoma (2009) Int J Cancer, 125, pp. 104-114
• Perillo, N.L., Pace, K.E., Seilhamer, J.J., Baum, L.G., Apoptosis of T cells mediated by galectin-1 (1995) Nature, 378 (6558), pp. 736-739
• Blaser, C., Kaufmann, M., Muller, C., Zimmermann, C., Wells, V., Mallucci, L., Pircher, H., Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells (1998) European Journal of Immunology, 28 (8), pp. 2311-2319. , DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0. CO;2-G
• Shurin, G.V., Gerein, V., Lotze, M.T., Barksdale Jr., E.M., Apoptosis induced in T cells by human neuroblastoma cells: Role of Fas ligand (1998) Nat Immun, 16, pp. 263-274
• Wolfl, M., Jungbluth, A.A., Garrido, F., Cabrera, T., Meyen-Southard, S., Spitz, R., Ernestus, K., Berthold, F., Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma (2005) Cancer Immunology, Immunotherapy, 54 (4), pp. 400-406. , DOI 10.1007/s00262-004-0603-z
• Xu, H., Cheung, I.Y., Guo, H.F., Cheung, N.K., MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: Potential implications for immune based therapy of human solid tumors (2009) Cancer Res, 69, pp. 6275-6281
• Siva, A., Xin, H., Qin, F., Oltean, D., Bowdish, K.S., Kretz-Rommel, A., Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200 (2008) Cancer Immunol Immunother, 57, pp. 987-996
• Contardi, E., Palmisano, G.L., Tazzari, P.L., Martelli, A.M., Fala, F., Fabbi, M., Kato, T., Pistillo, M.P., CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction (2005) International Journal of Cancer, 117 (4), pp. 538-550. , DOI 10.1002/ijc.21155
• Morandi, F., Levreri, I., Bocca, P., Galleni, B., Raffaghello, L., Ferrone, S., Prigione, I., Pistoia, V., Human neuroblastoma cells trigger an immunosuppressive program in monocytes by stimulating soluble HLA-G release (2007) Cancer Research, 67 (13), pp. 6433-6441. , http://cancerres.aacrjournals.org/cgi/reprint/67/13/6433, DOI 10.1158/0008-5472.CAN-06-4588
• Yan, X., Orentas, R.J., Johnson, B.D., Tumor-derived macrophage migration inhibitory factor (MIF) inhibits T lymphocyte activation (2006) Cytokine, 33, pp. 188-198
• Raffaghello, L., Prigione, I., Airoldi, I., Camoriano, M., Levreri, I., Gambini, C., Pende, D., Pistoia, V., Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma (2004) Neoplasia, 6 (5), pp. 558-568. , DOI 10.1593/neo.04316
• Fontana, A., Bodmer, S., Frei, K., Malipiero, U., Siepl, C., Expression of TGF-beta 2 in human glioblastoma: A role in resistance to immune rejection? (1991) Ciba Found Symp, 157, pp. 232-238
• Song, L., Ara, T., Wu, H.-W., Woo, C.-W., Reynolds, C.P., Seeger, R.C., DeClerck, Y.A., Metelitsa, L.S., Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma (2007) Journal of Clinical Investigation, 117 (9), pp. 2702-2712. , http://www.jci.org/cgi/reprint/117/9/2702, DOI 10.1172/JCI30751
• Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation (2009) Nat Rev Immunol, 9, pp. 338-352
• Sigal, R.K., Lieberman, M.D., Reynolds, J.V., Shou, J., Ziegler, M.M., Daly, J.M., Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy (1991) J Pediatr Surg, 26, pp. 389-395
• Muranski, P., Restifo, N.P., Adoptive immunotherapy of cancer using CD4(+) T cells (2009) Curr Opin Immunol, 21, pp. 200-208
• Giguere, D., Bonin, M.A., Cloutier, P., Patnam, R., St-Pierre, C., Sato, S., Roy, R., Synthesis of stable and selective inhibitors of human galectins-1 and -3 (2008) Bioorg Med Chem, 16, pp. 7811-7823
• Ingrassia, L., Camby, I., Lefranc, F., Mathieu, V., Nshimyumukiza, P., Darro, F., Kiss, R., Anti-galectin compounds as potential anti-cancer drugs (2006) Current Medicinal Chemistry, 13 (29), pp. 3513-3527. , http://www.ingentaconnect.com/content/ben/cmc/2006/00000013/00000029/ art00003, DOI 10.2174/092986706779026219
• Rabinovich, G.A., Cumashi, A., Bianco, G.A., Ciavardelli, D., Iurisci, I., D'Egidio, M., Piccolo, E., Iacobelli, S., Synthetic lactulose amines: Novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology, 16 (3), pp. 210-220. , DOI 10.1093/glycob/cwj056
• Salomonsson, E., Thijssen, V.L., Griffioen, A.W., Nilsson, U.J., Leffler, H., The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins (2011) J Biol Chem, 286, pp. 13801-13804
• Stannard, K.A., Collins, P.M., Ito, K., Sullivan, E.M., Scott, S.A., Gabutero, E., Darren, G.I., Ralph, S.J., Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model (2010) Cancer Lett, 299, pp. 95-110
• Huebener, N., Fest, S., Strandsby, A., Michalsky, E., Preissner, R., Zeng, Y., Gaedicke, G., Lode, H.N., A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity (2008) Mol Cancer Ther, 7, pp. 2241-2251
• Li, L., Li, S.-P., Min, J., Zheng, L., Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells (2007) Immunology Letters, 114 (1), pp. 38-45. , DOI 10.1016/j.imlet.2007.09.003, PII S0165247807002064
• Martin, P., Del, H.G.M., Anjuere, F., Arias, C.F., Vargas, H.H., Fernandez-L, A., Parrillas, V., Ardavin, C., Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential (2002) Blood, 100 (2), pp. 383-390. , DOI 10.1182/blood.V100.2.383
• Walker, S.R., Redlinger Jr., R.E., Barksdale Jr., E.M., Neuroblastoma-induced inhibition of dendritic cell IL-12 production via abrogation of CD40 expression (2005) J Pediatr Surg, 40, pp. 244-249
• Johnson, B.D., Jing, W., Orentas, R.J., CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma (2007) Journal of Immunotherapy, 30 (2), pp. 203-214. , DOI 10.1097/01.cji.0000211336.91513.dd, PII 0000237120070200000007

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------